Karteris E

No ORCID on file · 9 papers in corpus · active 2003-2025

Study types

  • article 1
  • letter 1
  • review 1

Condition tags

  • endometriosis 3
2025
Molecules (Basel, Switzerland) ·doi:10.3390/molecules30163410

(1) Background: Following the discovery of the adipokine/hormone asprosin, a substantial amount of research has provided evidence for its role in the regulation of glucose homeostasis, as well as appetite, and insulin sensitivity. Its level…

2024
Cancers ·doi:10.3390/cancers16030582

BackgroundProtein Tyrosine Phosphatase Receptor Type D (PTPRD) is involved in the regulation of cell growth, differentiation, and oncogenic transformation, as well as in brain development. PTPRD also mediates the effects of asprosin, which …

review 2024
Cancers ·doi:10.3390/cancers16112160

Ovarian cancer is an umbrella term covering a number of distinct subtypes. Endometrioid and clear-cell ovarian carcinoma are endometriosis-associated ovarian cancers (EAOCs) frequently arising from ectopic endometrium in the ovary. The mech…

2021
Journal of clinical medicine ·doi:10.3390/jcm10091979

Endocrine-disrupting chemicals (EDCs) can exert multiple deleterious effects and have been implicated in carcinogenesis. The xenoestrogen Bisphenol A (BPA) that is found in various consumer products has been involved in the dysregulation of…

2020
Experimental and therapeutic medicine ·doi:10.3892/etm.2020.9308

Implantation is the final and most important stage of embryogenesis and is of paramount importance in achieving a successful pregnancy. Progesterone and estrogen are steroid hormones responsible for the regulation of the implantation window…

2020
Journal of clinical medicine ·doi:10.3390/jcm9103296

Infection by the severe acute respiratory syndrome (SARS) coronavirus-2 (SARS-CoV-2) is the causative agent of a new disease (COVID-19). The risk of severe COVID-19 is increased by certain underlying comorbidities, including asthma, cancer,…

article 2018
International journal of molecular medicine ·doi:10.3892/ijmm.2018.3967

Endometriosis is a well‑known risk factor for ovarian cancer. The genetic changes that characterise endometriosis are poorly understood; however, the mechanistic target of rapamycin (mTOR) pathway is involved. In this study, we investigated…

2016
International journal of oncology ·doi:10.3892/ijo.2016.3531

Ovarian cancer is the second most common gynaecological malignancy and was diagnosed in over 7,000 women in 2011 in the UK. There are currently no reliable biomarkers available for use in a regular screening assay for ovarian cancer and due…

letter 2003
Fertility and Sterility ·doi:10.1016/s0015-0282(03)02204-0